EMA Authorised: Cerdelga (Eliglustat (tartrate)) — Sanofi B.V.

View source ↗

Summary

Cerdelga (Eliglustat tartrate) has been authorised by EMA for Gaucher disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease

Drugs mentioned

• Cerdelga (Eliglustat)

Snippet

Status: Authorised. Therapeutic area: Gaucher Disease. MAH: Sanofi B.V.. Decision date: 23/07/2026. Orphan medicine